Get the Stockscreener App
104.81
0.33%
0.34
After Hours:
104.81
Zimmer Biomet Holdings Inc stock is traded at $104.81, with a volume of 2.43M.
It is up +0.33% in the last 24 hours and down -4.34% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$104.47
Open:
$105.51
24h Volume:
2.43M
Relative Volume:
1.64
Market Cap:
$21.34B
Revenue:
$7.52B
Net Income/Loss:
$997.10M
P/E Ratio:
43.49
EPS:
2.41
Net Cash Flow:
$1.11B
1W Performance:
-9.22%
1M Performance:
-4.34%
6M Performance:
-16.71%
1Y Performance:
-14.56%
1-Day Range:
$104.04
$105.51
1-Week Range:
$104.04
$116.71
52-Week Range:
$102.00
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet falls on potential revenue hit from software issue - MSN
Zimmer Biomet (NYSE:ZBH) Given New $119.00 Price Target at TD Cowen - MarketBeat
Victory Capital Management Inc. Acquires 211,637 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet (NYSE:ZBH) Receives In-Line Rating from Evercore ISI - MarketBeat
FDA clears Zimmer Biomet Persona Knee with Think Surgical robot - Mass Device
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Zimmer Biomet Stock Falls After the Medtech Firm Warns of Software Switch Impact - Yahoo Finance
Zimmer Biomet (NYSE:ZBH) Shares Gap Down to $114.48 - MarketBeat
Traders Purchase High Volume of Zimmer Biomet Put Options (NYSE:ZBH) - MarketBeat
Stifel maintains Buy rating on Zimmer Biomet - Investing.com
Zimmer Biomet stock falls on revenue warning (NYSE:ZBH) - Seeking Alpha
Zimmer Biomet has a new SVP of investor relations - Mass Device
Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations - StockTitan
Pseudarthrosis Treatment Market is Projected to Reach $1.37 Billion at a CAGR 4.6% by 2034 | Fact.MR Report - GlobeNewswire Inc.
Here's How Zimmer Biomet (ZBH) is Poised Ahead of Q2 Earnings - Yahoo Finance
Cartilage Repair Market Growing Rapidly by 2031Johnson & - openPR
Farther Finance Advisors LLC Purchases 4,807 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Medical Robotics Surgery Market to Grow at CAGR of 10.82% through 2033 - GlobeNewswire Inc.
9,600 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Acquired by Versor Investments LP - MarketBeat
Global Dental Implant Market Report 2024-2032 Featuring Strategic Analysis of Danaher, Dentsply Sirona, Institut Straumann, Zimmer Biomet, and Kyocera Among Others - Yahoo Finance UK
The 10 Best Companies to Invest in Now - Morningstar
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Simply Wall St
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Principal Financial Group Inc. - MarketBeat
Zacks Research Analysts Decrease Earnings Estimates for Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Purchased by Van ECK Associates Corp - MarketBeat
Market Share Gains Aid Zimmer Biomet Stock Amid Cost Pressure - MSN
Zimmer Biomet Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Market Share Gains Aid Zimmer Biomet Stock Amid Cost Pressure - Yahoo Finance
Q1 2025 Earnings Estimate for Zimmer Biomet Holdings, Inc. Issued By Zacks Research (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. Plans Quarterly Dividend of $0.24 (NYSE:ZBH) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Sells 204,074 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024 - StockTitan
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024 - WV News
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024 - Longview News-Journal
Jim Cramer on Zimmer Biomet Holdings, Inc. (ZBH): ‘This Stock's Actually Down 11% for the Year' - MSN
Kintegral Advisory LLC Boosts Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Orthopedic Power Tools Market Growing Rapidly by 2031- Zimmer - openPR
Zimmer Biomet Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
Liontrust Investment Partners LLP Sells 123,287 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly - Simply Wall St
ZBH: 3 High-Growth MedTech Stocks to Buy - StockNews.com
Bank of New York Mellon Corp Sells 156,476 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet announces increased net sales in second-quarter 2024 financial results - Healio
Easterly Investment Partners LLC Decreases Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
New York State Teachers Retirement System Has $20.32 Million Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Ankle Replacement Devices Market to Witness Huge Growth by 2031 - openPR
Global Orthopedic Biomaterials Market Size To Worth USD 51.50 Billion By 2033 | CAGR Of 10.20% - GlobeNewswire Inc.
Global Tooth Regeneration Market Size To Worth USD 8.20 Billion By 2033 | CAGR Of 6.18% - GlobeNewswire Inc.
ZBHZimmer Biomet Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.32%
0.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):